Due to the potential importance for the CDKN2A C500G polymorphism and IDH1 mutations in GBM, the current study investigated the C and G 500 allele frequencies in genomic DNA, and IDH1 mutations in tumor DNA from 107 individuals with telomerase, ALT, and NDTMM GBMs. This evidence concerns the gene IDH1 and neoplasm.